Related Experiment Video
Updated: Mar 14, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
MicroRNA-221-3p Plays an Oncogenic Role in Gastric Carcinoma by Inhibiting PTEN Expression
Jianping Shi1, Yi Zhang2, Nuyun Jin1
1Department of Digestion, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, P.R. China.
Abstract:
Gastric carcinoma is one of the most common malignancies in men, and microRNA plays a critical role in regulating the signaling networks of gastric carcinoma tumorigenesis and metastasis. We first report the functional characteristics of miR-221-3p in gastric carcinoma. Quantification in gastric carcinoma cell lines and tumor samples reveals significantly increasing miR-221-3p expression. Moreover, a high level of miR-221-3p is correlated with a poor prognosis for gastric carcinoma patients. Ectopic miR-221-3p expression significantly promotes gastric carcinoma cell proliferation, invasion, and sphere formation, while silencing miR-221-3p significantly inhibits these abilities in gastric carcinoma cells. Tests in vivo showed that miR-221-3p significantly promotes tumor growth in xenograft mouse models. In this study, we reveal that miR-221-3p targets PTEN mRNA and downregulates PTEN, which is the possible mechanism of miR-221-3p-induced oncogenic properties. Collectively, we reveal a critical role for miR-221-3p in gastric carcinoma development and progression.
Insights
MicroRNA miR-221-3p promotes gastric carcinoma growth and spread. This microRNA targets PTEN, offering a potential therapeutic target for this common male malignancy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastric carcinoma is a prevalent malignancy, particularly in men.
- MicroRNAs are key regulators in cancer development and metastasis.
- The specific role of miR-221-3p in gastric carcinoma remains largely unexplored.
Purpose of the Study:
- To investigate the functional role of miR-221-3p in gastric carcinoma.
- To determine the correlation between miR-221-3p expression and patient prognosis.
- To elucidate the molecular mechanism underlying miR-221-3p's function in gastric cancer.
Main Methods:
- Quantification of miR-221-3p expression in gastric cancer cell lines and patient tumor samples.
- In vitro functional assays (proliferation, invasion, sphere formation) with miR-221-3p overexpression and silencing.
- In vivo studies using xenograft mouse models.
- Identification of miR-221-3p targets using molecular techniques.
Main Results:
- miR-221-3p expression is significantly elevated in gastric carcinoma.
- High miR-221-3p levels correlate with poor patient prognosis.
- Overexpression of miR-221-3p enhances cancer cell proliferation, invasion, and sphere formation.
- Silencing miR-221-3p inhibits these oncogenic properties.
- miR-221-3p promotes tumor growth in vivo.
- miR-221-3p directly targets PTEN mRNA, downregulating its expression.
Conclusions:
- miR-221-3p acts as an oncogene in gastric carcinoma.
- The miR-221-3p/PTEN axis is a critical pathway in gastric cancer progression.
- miR-221-3p represents a potential therapeutic target for gastric carcinoma.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

